CD19 and lymphoma: The marked delay in lymphoma development seen in the Eμ-Myc;Rag-1-Cre;Mcl-1fl/+ mice suggested that Rag-1-Cre was considerably more efficient in Mcl-1fl deletion than CD19-Cre.